Ozempic vs Mounjaro - Investing in Pharmaceuticals cover art

Ozempic vs Mounjaro - Investing in Pharmaceuticals

Ozempic vs Mounjaro - Investing in Pharmaceuticals

Listen for free

View show details

About this listen

 Ozempic (NVO) and Mounjaro (LLY) are dominating headlines due to radical obesity medication — but what does that mean for traders and investors? We analyse the pharmaceutical market potential and blockbuster future drugs. Plus: Trump tariff u-turns. What traders need to know.

Hosted on Acast. See acast.com/privacy for more information.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.